BioTechnology News
- Swiss trial opens for 3 accused eco-terrorists Tuesday, July 19, 2011 @ 8:05AMThree accused eco-terrorists went on trial under heavy security in Switzerland's highest criminal court Tuesday for an alleged plot to blow up an IBM nanotech research center near Zurich.
- Webcast of QIAGEN N.V.'s (Nasdaq:QGEN) Second Quarter 2011 Financial Results Call Set for July 26 Tuesday, July 19, 2011 @ 8:00AMVENLO, The Netherlands -- QIAGEN N.V. today announced the Webcast of its second quarter 2011 financial results call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, July 26, and will include remarks by Peer M.
- Canary Center at Stanford Adopts Syapse to Accelerate Early Cancer Detection Research Tuesday, July 19, 2011 @ 8:00AMSyapse announced today that the Canary Center at Stanford for Cancer Early Detection has adopted Syapse's cloud-based, Biomedical Development Management software to accelerate translational research aimed at earlier cancer detection using novel diagnostic systems.
- Swiss trial opens for 3 accused of trying to blow up IBM nanotech centre in Zurich Tuesday, July 19, 2011 @ 7:59AMBELLINZONA, Switzerland - Three accused eco-terrorists went on trial under heavy security in Switzerland's highest criminal court Tuesday for an alleged plot to blow up an IBM nanotech research centre near Zurich.
- BioTime Announces the Issuance of a Second U.S. Glycosan Hydrogel Patent Tuesday, July 19, 2011 @ 7:56AMBioTime, Inc. (NYSE Amex: BTX) announced today the issuance of United States patent number 7,981,871 titled "Modified Macromolecules and Associated ...
- New Human Imaging Data Support the Neuroprotective Effects of Allon's Davunetide Tuesday, July 19, 2011 @ 7:45AMVANCOUVER, BRITISH COLUMBIA--(Marketwire - July 19, 2011) - Allon Therapeutics Inc . (TSX:NPC) today announced new findings that 12 weeks of treatment with the Company's lead product davunetide appears to prevent cortical thinning of important parts of the brains of schizophrenia patients.
- Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion Tuesday, July 19, 2011 @ 7:39AMJohnson & Johnson today announced sales of $16.6 billion for the second quarter of 2011, an increase of 8.3% as compared to the second quarter of 2010.
- Intnl. Biotechnology - Net Asset Value(s) Tuesday, July 19, 2011 @ 7:39AMIntnl. Biotechnology - Net Asset Value(s)
- Could Novartis' Earnings Be Good For Regeneron? Tuesday, July 19, 2011 @ 7:32AMOne analyst argues that the performance of Novartis' Lucentis could be good for Regeneron.
- Vietnam Keen To Emulate And Learn From Malaysia Monday, July 18, 2011 @ 6:26AMKUALA LUMPUR, July 18 (Bernama) -- Vietnam is keen to emulate and learn from Malaysia to upgrade its information communications technology (ICT) infrastructure by 2020, says Vietnam Minister of Information and Communications, Dr Le Doan Hop.
- Norfolk featured in culinary guide Monday, July 18, 2011 @ 6:18AMNorfolk's farmers and restaurants figure prominently in the latest edition of Ontario's Southwest Culinary Guide.[...]
- Social Interest Solutions Delivers Patient Assistance Link, a Fully Automated Application for Securing Medications ... Monday, July 18, 2011 @ 6:11AMSACRAMENTO, Calif.--(BUSINESS WIRE)--Social Interest Solutions (SIS), a mission-driven, nonprofit organization dedicated to leveraging technology innovation to improve consumers’ access to eligible health and human services, today announced the availability of Patient Assistance Link (PAL), a fully automated system dedicated to helping patients and those supporting them to obtain assistance for ...
- MarketsandMarkets: Global Wind Turbine Rotor Blade Market Will Reach $14.6 Billion With Annual Installations of 0.14 ... Monday, July 18, 2011 @ 5:39AMDALLAS, July 18, 2011 /PRNewswire/ According to a new market research report, "Global Wind Turbine Rotor Blade Market by Testing, Material, Blade Size, Regulations & Outlook (2011 - 2016) …
- Global Automotive Semiconductors Industry Forecast (2010 - 2014) Monday, July 18, 2011 @ 5:18AMReportlinker.com announces that a new market research report is available in its catalogue:
- Nigeria: U.S. and NABDA Partner On Renewable Energy Monday, July 18, 2011 @ 5:01AMThe United States of America said it would assist Nigeria overcome the energy crisis by providing grant to boost renewable energy projects in the country.
- Investors underwhelmed by Angel Biotech results Monday, July 18, 2011 @ 4:53AMLONDON (SHARECAST) - Angel Biotechnology slumped 7% after the biopharmaceutical contract manufacturer reported a net loss for the six months to 30 June as investors, who rejoiced the company’s maiden profit last year, turned sour on the company.
- Angel Biotech dips following swing into the red Monday, July 18, 2011 @ 4:43AMAIM -listed Angel Biotechnology (ABH) announced a net loss for the six months to June, disappointing investors by swinging back into the red.
- Foster Wheeler And SOCAR To Form A New Joint Venture Company In Azerbaijan Monday, July 18, 2011 @ 4:16AMFoster Wheeler AG announced today that a subsidiary of its Global Engineering and Construction Group has signed a Memorandum of Understanding (MoU) to cooperate to form a jointly-owned company with The State Oil Company of Azerbaijan Republic (SOCAR) in the Republic of Azerbaijan.
- Newly developed fluorescent protein makes internal organs visible Monday, July 18, 2011 @ 4:04AMResearchers at Albert Einstein College of Medicine of Yeshiva University have developed the first fluorescent protein that enables scientists to clearly "see" the internal organs of living animals without the need for a scalpel or imaging techniques that can have side effects or increase radiation exposure.
- Male GM salmon can breed with wild species, researchers find Thursday, July 14, 2011 @ 3:48PMOn the heels of a new international guideline encouraging the labelling of genetically modified foods, Canadian researchers have found that transgenic Atlantic salmon can pass their genes on to wild salmon if they escape into the wild.
- Seattle Children's Opens New Center for Childhood Cancer Research Thursday, July 14, 2011 @ 3:45PMCenter's immunotherapy research may eliminate the need for surgery, chemotherapy and radiation.
- Seattle Genetics Announces Unanimous Recommendations from FDA Advisory Committee in Favor of Accelerated Approval of ... Thursday, July 14, 2011 @ 3:41PMBOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT). In ...
- Who benefits from race-based science Thursday, July 14, 2011 @ 3:31PMA new book explores how big business and political systems benefit from classifying race as biological category.
- Vical and Astellas Announce Worldwide License Agreements for TransVax(TM) Cytomegalovirus Vaccine Thursday, July 14, 2011 @ 3:00PMVical to Receive up to $130 Million in Upfront and Development Milestones Plus Double-digit Royalties Vical to Conduct Conference Call and Webcast at 8:00 a.m. ET Friday
- Editing the genome: Scientists unveil new tools for rewriting the code of life Thursday, July 14, 2011 @ 2:21PMResearchers have unveiled genome-engineering technologies capable of fundamentally re-engineering genomes from the nucleotide to the megabase scale. Treating the chromosome as both an editable and an evolvable template, the researchers have demonstrated methods to rewrite a cell's genome through powerful new tools for biotechnology, energy and agriculture.
- Research and Development Partnership to Benefit Delaware Education, Economy Thursday, July 14, 2011 @ 1:24PMNEWARK, Del.--(BUSINESS WIRE)--New Partnership between Fraunhofer Center for Molecular Biotechnology, University of Delaware and State of Delaware will enhance research, development and commercialization of new technology.
- Editing the genome Thursday, July 14, 2011 @ 1:18PM( Harvard Medical School ) Researchers unveil genome-engineering technologies capable of fundamentally re-engineering genomes from the nucleotide to the megabase scale. Treating the chromosome as both an editable and an evolvable template, the researchers have demonstrated methods to rewrite a cell's genome through powerful new tools for biotechnology, energy and agriculture.
- CMRC Nationals at Gopher Dunes Thursday, July 14, 2011 @ 1:17PMMonster Energy CMRC Nationals hit Gopher Dunes this weekend.[...]
- Today in photos — July 14 Thursday, July 14, 2011 @ 1:17PMLocal photos from the July 14, 2011 edition of the Simcoe Reformer[...]
- Sequana Medical Receives CE Mark Approval for the ALFApumpâ„¢ System and Adds Key Executive to Team Wednesday, July 13, 2011 @ 12:08AMZURICH, Switzerland, July 13, 2011 /PRNewswire/ New Technology Expands Treatment Options for Patient With Refractory Ascites Due to Liver Cirrhosis. Dr. Farzana Malik Joins as Vice President of Market Access and Reimbursement. Sequana Medical …
- Sequana Medical Receives CE Mark Approval for the ALFApump System and Adds Key Executive to Team Wednesday, July 13, 2011 @ 12:00AM-
- Positive results from sarilumab Phase 2b trial on RA, ankylosing spondylitis Tuesday, July 12, 2011 @ 11:48PMSanofi and Regeneron Pharmaceuticals, Inc. today announced results from Phase 2b trials in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with sarilumab, a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor.
- Arena reports APD811 Phase 1 trial results against pulmonary arterial hypertension Tuesday, July 12, 2011 @ 11:33PMArena Pharmaceuticals, Inc. announced today results from a Phase 1 clinical trial of APD811, an orally bioavailable agonist of the prostacyclin receptor which is intended for the treatment of pulmonary arterial hypertension, or PAH.
- Wedge issues: Why watermelon is a health food Tuesday, July 12, 2011 @ 11:19PMOn a hot summer day, a slice of cold watermelon can be wonderful. But watermelon is more than just a cool, refreshing treat. Watermelon contains high levels of nutrients that make it a valuable addition to any diet.
- APEC hosts target China market with invite to Chinese media Tuesday, July 12, 2011 @ 10:58PMBy Teri Okita – bio | email HONOLULU (HawaiiNewsNow) - Just four months to go until the unprecedented APEC event in Honolulu. The APEC host committee is already laying the groundwork for publicizing the
- Biotech company to sign deal with Chinese Tuesday, July 12, 2011 @ 10:30PMA local biotechnology company will officially make its first foray today into doing business in China, the first of what it hopes will be many. At a ceremony today at City Hall, Performance Plants Inc.[...]
- Joanna Rees: Bringing the Entrepreneurial Spirit Back to City Government Tuesday, July 12, 2011 @ 10:15PMIn San Francisco, I found a city that shared my values and reflected my experience: celebrating diversity, promoting strong neighborhoods, and embracing the entrepreneurial spirit.
- Steve Westly: California Will Rise Again Tuesday, July 12, 2011 @ 10:00PMIs it time to write-off California as an overly liberal social experiment destined to fail in the 21st century? Not for a minute. The very things that have made California the world's eighth largest economy will keep California on top for decades.
- Guilty plea in Seattle Genetics insider-trading scheme Tuesday, July 12, 2011 @ 6:09PMA California man implicated in an insider-trading scheme against a Seattle biotechnology firm has pleaded guilty.
- Second Croda deal for Aquapharm Tuesday, July 12, 2011 @ 6:09PMAquapharm, the Oban-based biotechnology company led by former Ardana chief executive Simon Best, yesterday signed a second deal with Sederma, the cosmetics subsidiary of chemi
- City hall selling Guelph abroad Tuesday, July 12, 2011 @ 5:58PM— Some travelling salespeople sell vacuum cleaners. Others hawk life insurance. Jim Mairs sells the City of Guelph.
- Former Gainesville biotech sold for $34 million Tuesday, July 12, 2011 @ 5:45PMEraGen Biosciences, a biotechnology company that has its origins in Gainesville, is being purchased by Luminex to the tune of $34 million.
- Novartis: A Common Sense Approach to Biotech Tuesday, July 12, 2011 @ 5:43PMBy Kendall J. Anderson"These bold and foolish lambs are lured by noise to every treacherous abyss"- ...
- EDITORIAL: Investing in innovation, loan-free Tuesday, July 12, 2011 @ 4:51PMHigh school graduates have long been told, "A college education is always a good investment." Student loan debt? No problem. It's more than offset by the increased earning potential and better job prospects that come with a college degree.But with tuition costs rising as fast as...
- Fitch Rates New Haven, CT's GOs 'A+'; Outlook Stable Tuesday, July 12, 2011 @ 4:43PMNEW YORK--(BUSINESS WIRE)--Fitch Ratings assigns the following rating to New Haven, Connecticut's (the city) bonds: --$44.5 million general obligation (GO) bonds, series 2011B rated 'A+'. In addition, Fitch has affirmed the 'A+' rating on the city's $498 million of outstanding GO bonds. The Rating Outlook is Stable. RATING RATIONALE: --The city's financial flexibility is limited and reserve ...
- INC Research Completes Acquisition of Kendle International Tuesday, July 12, 2011 @ 3:52PMStrategic Combination Creates Leading Global CRO Well-Positioned to Capitalize on Trends in Drug Development Outsourcing
- Trade Groups Gain Feds' Ear Tuesday, July 12, 2011 @ 3:44PMCEOs of Massachusetts biotech and medical device companies who have had issues with new federal policies will gain direct access to the commissioner of their chief regulatory agency today.
- US investment flow remains high Saturday, July 9, 2011 @ 12:57AMNew York, July 9 (Bernama) -- The United States of America, which is the largest single investor in Malaysia, continues to retain the number one slot in the first four months of 2011.
- GVSU Master’s Program is a First for West Michigan Saturday, July 9, 2011 @ 12:52AMBiomedical engineering professions among fastest growing in state, nation. Grand Rapids, MI (PRWEB) July 07, 2011 For the first time in West Michigan, students can further their education in one of the fastest growing professions in the nation. Grand Valley State University is the first university in West Michigan to offer a graduate-level degree program in biomedical engineering and it is the ...
- Texas A&M equine program gets $2.5M grant Saturday, July 9, 2011 @ 12:50AMThe equine program at Texas A&M is on the rise after receiving a $2.5 million grant in honor of Dr. Glenn Blodgett, a distinguished CVM alumnus. The equine initiative, a partnership between CVM, the College of Agriculture and Life Science and t ...
